Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2.
暂无分享,去创建一个
[1] Guido Silvestri,et al. Viral and host factors in the pathogenesis of HIV infection. , 2005, Current opinion in immunology.
[2] H. Ljunggren,et al. Development and function of CD1d-restricted NKT cells: influence of sphingolipids, SAP and sex. , 2005, Trends in immunology.
[3] J. Metcalf,et al. In vivo expansion of CD4+CD45RO–CD25+ T cells expressing foxP3 in IL-2-treated HIV-infected patients , 2005 .
[4] Sebastian Bonhoeffer,et al. The HIV coreceptor switch: a population dynamical perspective. , 2005, Trends in microbiology.
[5] D. Pellicci,et al. Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples , 2005, European journal of immunology.
[6] K. Weinberg,et al. Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans. , 2004, Blood.
[7] M. Kronenberg,et al. Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.
[8] R. Lempicki,et al. IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. , 2004, Blood.
[9] D. Nixon,et al. Development of innate CD4+ α-chain variable gene segment 24 (Vα24) natural killer T cells in the early human fetal thymus is regulated by IL-7 , 2004 .
[10] D. Follmann,et al. Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. , 2004, Blood.
[11] D. Nixon,et al. Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Vα24 NKT cell compartment , 2003, European journal of immunology.
[12] É. Oksenhendler,et al. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial , 2003, AIDS.
[13] D. Nixon,et al. Selective Loss of Innate CD4+ Vα24 Natural Killer T Cells in Human Immunodeficiency Virus Infection , 2002, Journal of Virology.
[14] R. Lempicki,et al. Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] Michael P Busch,et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection , 2002, AIDS.
[16] D. Haas,et al. CD1d-restricted Human Natural Killer T Cells Are Highly Susceptible to Human Immunodeficiency Virus 1 Infection , 2002, The Journal of experimental medicine.
[17] G. Giaccone,et al. Selective Decrease in Circulating Vα24+Vβ11+ NKT Cells During HIV Type 1 Infection1 , 2002, The Journal of Immunology.
[18] J. Metcalf,et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. , 1996, The New England journal of medicine.
[19] S. Balk,et al. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain , 1993, The Journal of experimental medicine.
[20] J. Metcalf,et al. In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. , 2005, The Journal of clinical investigation.
[21] D. Nixon,et al. Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Dybul,et al. Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. , 2002, The Journal of infectious diseases.
[23] G. Giaccone,et al. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. , 2002, Journal of Immunology.